Nanoviricides, Inc.
NNVC· NYSE
Released Nov 16, 2026, after the close
10-Q filed Nov 16, 2026, 47 days after period end · 0001104659-26-128532
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2027 | Q1 2026 | Q1 2025 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$5.74M | -$1.79M | -$3.13M | -$1.97M |
| EPS Diluted | -$0.23 |
Nanoviricides, Inc. · CIK 1379006 · Engraved from SEC EDGAR
| -$0.10 |
| -$0.23 |
| -$0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.